The 1+1 Trial
Open Access
- 31 August 2004
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Circulation
- Vol. 110 (9) , 1022-1029
- https://doi.org/10.1161/01.cir.0000140259.16185.7d
Abstract
Background— The tachycardia detection interval (TDI) in implantable cardioverter/defibrillators (ICDs) is conventionally programmed according to the slowest documented ventricular tachycardia (VT), with a safety margin of 30 to 60 ms. With this margin, VTs above the TDI may occur. However, longer TDIs are associated with an increased risk of inappropriate therapy. We hypothesized that patients with slow VTs (Methods and Results— Patients with VTs 2 minutes). After 6 months, a crossover analysis was performed. Total follow-up was 1 year. One hundred two patients were included in the study. The programmed TDI was 500±36 ms during the dual-chamber phase and 424±63 ms during the single-chamber phase. For the primary end point (inappropriate therapies, VTs above the TDI, or VTs with detection delay), a moderate superiority of the dual-chamber mode was found: Mann-Whitney estimator=0.6661; 95% CI, 0.5565 to 0.7758; P =0.0040. Conclusions— Dual-chamber detection with a longer TDI improves VT detection and does not increase the rate of inappropriate therapies despite a considerable increase in tachycardia burden.Keywords
This publication has 24 references indexed in Scilit:
- Underdetection of Ventricular Tachycardia Using a 40 ms Stability Criterion: Effect of Antiarrhythmic TherapyPacing and Clinical Electrophysiology, 1997
- Radiofrequency Catheter Ablation of Atrial Flutter That Elicits Inappropriate Implantable Cardioverter Defibrillator DischargePacing and Clinical Electrophysiology, 1997
- Programmable VT Detection Enhancements in Implantable Cardioverter Defibrillator TherapyPacing and Clinical Electrophysiology, 1995
- Underdetection of ventricular tachycardia by algorithms to enhance specificity in a tiered-therapy cardioverter-defibrillatorJournal of the American College of Cardiology, 1994
- Response to sotalol predicts the response to amiodarone during serial drug testing in patients with sustained ventricular tachycardia and coronary artery diseaseThe American Journal of Cardiology, 1994
- Arrhythmias induced by device antitachycardia therapy due to diagnostic nonspecificityJournal of the American College of Cardiology, 1991
- Efficacy of class Ib (lidocaine-like) antiarrhythmic agents for prevention of sustained ventricular tachycardia secondary to coronary artery diseaseThe American Journal of Cardiology, 1987
- Short- and long-term experience with flecainide acetate in the management of refractory life-threatening ventricular arrhythmiasJournal of the American College of Cardiology, 1985
- Model building and testing for the change‐over designBiometrical Journal, 1980
- 328. Note: The Use of None-Parametric Methods in the Statistical Analysis of the Two-Period Change-Over DesignPublished by JSTOR ,1972